Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: March 3, 2026, 1:51 pm
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532719 | NSE: BLKASHYAP

BL Kashyap & Sons Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 3, 2026, 1:51 pm

Market Cap 1,141 Cr.
Current Price 50.6
Intrinsic Value₹36.77
High / Low 80.1/42.7
Stock P/E128
Book Value 23.3
Dividend Yield0.00 %
ROCE8.08 %
ROE2.00 %
Face Value 1.00
PEG Ratio-5.24

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for BL Kashyap & Sons Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
BL Kashyap & Sons Ltd 1,141 Cr. 50.6 80.1/42.7128 23.30.00 %8.08 %2.00 % 1.00
A B Infrabuild Ltd 1,146 Cr. 17.9 23.6/7.0256.4 2.460.03 %18.4 %17.3 % 1.00
Arihant Superstructures Ltd 1,116 Cr. 258 468/24824.6 81.20.58 %11.1 %18.8 % 10.0
Arihant Foundations & Housing Ltd 1,038 Cr. 1,041 1,513/62215.3 3450.00 %19.5 %16.5 % 10.0
Vascon Engineers Ltd 844 Cr. 36.9 74.6/32.211.0 49.30.00 %7.76 %6.59 % 10.0
Industry Average3,614.73 Cr160.9137.77125.470.17%16.37%21.40%21.58

All Competitor Stocks of BL Kashyap & Sons Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 253276253327324341350267242294336355324
Expenses 231253228298300308319247236287310335295
Operating Profit 222325292433322067262029
OPM % 9%8%10%9%7%10%9%8%3%2%8%6%9%
Other Income 9-303118912915321
Interest 12131111121511141012111110
Depreciation 2223333333344
Profit before tax 16-231417102227152715816
Tax % -129%41%28%29%31%-6%24%38%41%149%26%212%25%
Net Profit 37-3210127242091-311-912
EPS in Rs 1.62-1.420.440.530.311.050.900.420.05-0.140.48-0.380.52

Last Updated: March 3, 2026, 12:00 pm

Below is a detailed analysis of the quarterly data for BL Kashyap & Sons Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 324.00 Cr.. The value appears to be declining and may need further review. It has decreased from 355.00 Cr. (Sep 2025) to 324.00 Cr., marking a decrease of 31.00 Cr..
  • For Expenses, as of Dec 2025, the value is 295.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 335.00 Cr. (Sep 2025) to 295.00 Cr., marking a decrease of 40.00 Cr..
  • For Operating Profit, as of Dec 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Sep 2025) to 29.00 Cr., marking an increase of 9.00 Cr..
  • For OPM %, as of Dec 2025, the value is 9.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Sep 2025) to 9.00%, marking an increase of 3.00%.
  • For Other Income, as of Dec 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Sep 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
  • For Interest, as of Dec 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Sep 2025) to 10.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Dec 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 4.00 Cr..
  • For Profit before tax, as of Dec 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Sep 2025) to 16.00 Cr., marking an increase of 8.00 Cr..
  • For Tax %, as of Dec 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 212.00% (Sep 2025) to 25.00%, marking a decrease of 187.00%.
  • For Net Profit, as of Dec 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from -9.00 Cr. (Sep 2025) to 12.00 Cr., marking an increase of 21.00 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 0.52. The value appears strong and on an upward trend. It has increased from -0.38 (Sep 2025) to 0.52, marking an increase of 0.90.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 12:00 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,3498348609241,0127698207621,1581,1101,2451,1541,310
Expenses 1,2968167928349277137996991,0671,0121,1341,0881,227
Operating Profit 531968898557216390981106583
OPM % 4%2%8%10%8%7%3%8%8%9%9%6%6%
Other Income -6531230315-22741-16124521
Interest 97818283775969595551494744
Depreciation 23472113121212111010101214
Profit before tax -132-78-12-627-10-82-16621635045
Tax % -36%-26%-48%-181%23%-34%-23%8,490%33%-7%17%45%
Net Profit -85-58-6521-6-63-584422532711
EPS in Rs -4.14-2.82-0.290.240.98-0.28-2.79-2.591.950.982.331.220.48
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)31.76%89.66%183.33%320.00%-128.57%-950.00%7.94%175.86%-50.00%140.91%-49.06%
Change in YoY Net Profit Growth (%)0.00%57.89%93.68%136.67%-448.57%-821.43%957.94%167.93%-225.86%190.91%-189.97%

BL Kashyap & Sons Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:3%
5 Years:7%
3 Years:0%
TTM:-15%
Compounded Profit Growth
10 Years:9%
5 Years:22%
3 Years:-2%
TTM:-72%
Stock Price CAGR
10 Years:21%
5 Years:55%
3 Years:39%
1 Year:-35%
Return on Equity
10 Years:3%
5 Years:6%
3 Years:8%
Last Year:3%

Last Updated: September 5, 2025, 2:31 pm

Balance Sheet

Last Updated: February 1, 2026, 4:23 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 21212121222323232323232323
Reserves 444384379414476493436357400422474501503
Borrowings 682762797745605552520519380320310316309
Other Liabilities 695596637595645756839622629531606676774
Total Liabilities 1,8411,7621,8331,7741,7481,8241,8181,5201,4321,2951,4121,5161,608
Fixed Assets 1409099431414412311236230133154192220
CWIP 11713013995979495000200
Investments 2992993011111000000
Other Assets 1,2851,2441,2941,2471,2361,3161,4121,2841,2021,1621,2561,3231,388
Total Assets 1,8411,7621,8331,7741,7481,8241,8181,5201,4321,2951,4121,5161,608

Below is a detailed analysis of the balance sheet data for BL Kashyap & Sons Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
  • For Reserves, as of Sep 2025, the value is 503.00 Cr.. The value appears strong and on an upward trend. It has increased from 501.00 Cr. (Mar 2025) to 503.00 Cr., marking an increase of 2.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 309.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 316.00 Cr. (Mar 2025) to 309.00 Cr., marking a decrease of 7.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 774.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 676.00 Cr. (Mar 2025) to 774.00 Cr., marking an increase of 98.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 1,608.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,516.00 Cr. (Mar 2025) to 1,608.00 Cr., marking an increase of 92.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 220.00 Cr.. The value appears strong and on an upward trend. It has increased from 192.00 Cr. (Mar 2025) to 220.00 Cr., marking an increase of 28.00 Cr..
  • For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 1,388.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,323.00 Cr. (Mar 2025) to 1,388.00 Cr., marking an increase of 65.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 1,608.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,516.00 Cr. (Mar 2025) to 1,608.00 Cr., marking an increase of 92.00 Cr..

Notably, the Reserves (503.00 Cr.) exceed the Borrowings (309.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -23-35117245117164-23-18187207976
Cash from Investing Activity + -141-34-3-22-284142-14110-31-29
Cash from Financing Activity + 3540-89-243-45-160-6052-69-110-80-43
Net Cash Flow -25-7-1502214519-334

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-629.00-743.00-729.00-656.00-520.00-495.00-499.00-456.00-290.00-222.00-200.00-251.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 107169187156127176171210110138111138
Inventory Days 259414384333261372347201240105130
Days Payable 150188163118152170179116140136154
Cash Conversion Cycle 21539640737123637833921019523880113
Working Capital Days 37739413-19-7418441646894
ROCE %4%0%6%7%9%5%2%8%10%14%14%8%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 61.58%61.61%61.65%61.65%61.65%61.65%61.65%61.65%61.67%61.69%61.70%61.71%
FIIs 0.22%0.43%0.35%0.30%0.89%1.65%1.87%0.59%0.72%0.40%0.34%0.31%
DIIs 0.09%0.00%0.00%0.00%0.02%0.00%0.00%0.35%0.92%0.88%0.59%0.17%
Public 38.12%37.96%38.00%38.04%37.44%36.70%36.48%37.40%36.68%37.03%37.37%37.81%
No. of Shareholders 24,60225,09926,22530,43038,58139,13345,12245,65144,71244,23144,06643,801

Shareholding Pattern Chart

No. of Shareholders

BL Kashyap & Sons Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 1.222.330.981.95-2.59
Diluted EPS (Rs.) 1.222.330.981.95-2.59
Cash EPS (Rs.) 1.772.791.412.41-2.10
Book Value[Excl.RevalReserv]/Share (Rs.) 23.2322.0219.7318.7616.82
Book Value[Incl.RevalReserv]/Share (Rs.) 23.2322.0219.7318.7616.82
Revenue From Operations / Share (Rs.) 51.1755.2049.2451.3433.81
PBDIT / Share (Rs.) 4.065.435.224.103.90
PBIT / Share (Rs.) 3.514.974.793.643.41
PBT / Share (Rs.) 2.232.810.912.92-0.03
Net Profit / Share (Rs.) 1.222.330.981.95-2.59
NP After MI And SOA / Share (Rs.) 1.222.330.981.95-2.59
PBDIT Margin (%) 7.929.8410.607.9911.54
PBIT Margin (%) 6.859.009.727.0910.09
PBT Margin (%) 4.355.081.855.69-0.08
Net Profit Margin (%) 2.384.221.993.79-7.66
NP After MI And SOA Margin (%) 2.384.221.993.79-7.66
Return on Networth / Equity (%) 5.2410.584.9710.39-15.40
Return on Capital Employeed (%) 11.6017.1618.3312.3910.79
Return On Assets (%) 1.813.721.703.06-3.84
Long Term Debt / Equity (X) 0.070.060.080.150.29
Total Debt / Equity (X) 0.600.620.710.861.11
Asset Turnover Ratio (%) 0.780.910.810.760.44
Current Ratio (X) 1.401.371.361.211.27
Quick Ratio (X) 1.170.710.870.770.82
Inventory Turnover Ratio (X) 3.351.571.551.841.14
Interest Coverage Ratio (X) 1.932.512.291.691.48
Interest Coverage Ratio (Post Tax) (X) 1.192.082.131.100.32
Enterprise Value (Cr.) 1439.171822.80959.52931.69821.69
EV / Net Operating Revenue (X) 1.251.460.860.801.08
EV / EBITDA (X) 15.7314.888.1510.079.34
MarketCap / Net Operating Revenue (X) 1.001.240.630.510.55
Price / BV (X) 2.213.121.571.411.12
Price / Net Operating Revenue (X) 1.001.240.630.510.55
EarningsYield 0.020.030.030.07-0.13

After reviewing the key financial ratios for BL Kashyap & Sons Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For Cash EPS (Rs.), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 3. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.17. It has decreased from 55.20 (Mar 24) to 51.17, marking a decrease of 4.03.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 4.06, marking a decrease of 1.37.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 3.51. This value is within the healthy range. It has decreased from 4.97 (Mar 24) to 3.51, marking a decrease of 1.46.
  • For PBT / Share (Rs.), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 2.23, marking a decrease of 0.58.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
  • For PBDIT Margin (%), as of Mar 25, the value is 7.92. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 7.92, marking a decrease of 1.92.
  • For PBIT Margin (%), as of Mar 25, the value is 6.85. This value is below the healthy minimum of 10. It has decreased from 9.00 (Mar 24) to 6.85, marking a decrease of 2.15.
  • For PBT Margin (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 10. It has decreased from 5.08 (Mar 24) to 4.35, marking a decrease of 0.73.
  • For Net Profit Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 8. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 5.24. This value is below the healthy minimum of 15. It has decreased from 10.58 (Mar 24) to 5.24, marking a decrease of 5.34.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 11.60. This value is within the healthy range. It has decreased from 17.16 (Mar 24) to 11.60, marking a decrease of 5.56.
  • For Return On Assets (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 5. It has decreased from 3.72 (Mar 24) to 1.81, marking a decrease of 1.91.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.60, marking a decrease of 0.02.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 0.91 (Mar 24) to 0.78, marking a decrease of 0.13.
  • For Current Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.40, marking an increase of 0.03.
  • For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.71 (Mar 24) to 1.17, marking an increase of 0.46.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.35. This value is below the healthy minimum of 4. It has increased from 1.57 (Mar 24) to 3.35, marking an increase of 1.78.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 3. It has decreased from 2.51 (Mar 24) to 1.93, marking a decrease of 0.58.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 3. It has decreased from 2.08 (Mar 24) to 1.19, marking a decrease of 0.89.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 1,439.17. It has decreased from 1,822.80 (Mar 24) to 1,439.17, marking a decrease of 383.63.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.25, marking a decrease of 0.21.
  • For EV / EBITDA (X), as of Mar 25, the value is 15.73. This value exceeds the healthy maximum of 15. It has increased from 14.88 (Mar 24) to 15.73, marking an increase of 0.85.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
  • For Price / BV (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 3.12 (Mar 24) to 2.21, marking a decrease of 0.91.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
  • For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of BL Kashyap & Sons Ltd as of March 5, 2026 is: ₹48.67

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 5, 2026, BL Kashyap & Sons Ltd is Overvalued by 3.81% compared to the current share price ₹50.60

Intrinsic Value of BL Kashyap & Sons Ltd as of March 5, 2026 is: ₹36.77

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 5, 2026, BL Kashyap & Sons Ltd is Overvalued by 27.33% compared to the current share price ₹50.60

Last 5 Year EPS CAGR: -24.45%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
    1. The stock has a low average ROCE of 7.25%, which may not be favorable.
    2. The stock has a high average Working Capital Days of 48.58, which may not be favorable.
    3. The stock has a high average Cash Conversion Cycle of 264.83, which may not be favorable.
    4. The company has higher borrowings (524.38) compared to reserves (437.15), which may suggest financial risk.
    5. The company has not shown consistent growth in sales (382.77) and profit (-3.77).

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BL Kashyap & Sons Ltd:
      1. Net Profit Margin: 2.38%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 11.6% (Industry Average ROCE: 16.37%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 5.24% (Industry Average ROE: 21.4%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 1.19
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.17
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 128 (Industry average Stock P/E: 37.77)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0.6
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    B L Kashyap & Sons Ltd. is a Public Limited Listed company incorporated on 08/05/1989 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1989PLC036148 and registration number is 036148. Currently Company is involved in the business activities of Construction of buildings. Company's Total Operating Revenue is Rs. 1142.30 Cr. and Equity Capital is Rs. 22.54 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Construction, Contracting & Engineering409, 4th Floor, New Delhi Delhi 110025Contact not found
    Management
    NamePosition Held
    Mr. Vinod KashyapChairman
    Mr. Vineet KashyapManaging Director
    Mr. Vikram KashyapJoint Managing Director
    Mr. Vivek TalwarIndependent Director
    Mr. Settihalli BasavarajIndependent Director
    Mrs. Neelam Naresh KothariIndependent Director
    Mr. Gopinath AmbadithodyIndependent Director
    Mr. Vishal Sharat OhriNominee Director

    FAQ

    What is the intrinsic value of BL Kashyap & Sons Ltd?

    BL Kashyap & Sons Ltd's intrinsic value (as of 05 March 2026) is ₹36.77 which is 27.33% lower the current market price of ₹50.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,141 Cr. market cap, FY2025-2026 high/low of ₹80.1/42.7, reserves of ₹503 Cr, and liabilities of ₹1,608 Cr.

    What is the Market Cap of BL Kashyap & Sons Ltd?

    The Market Cap of BL Kashyap & Sons Ltd is 1,141 Cr..

    What is the current Stock Price of BL Kashyap & Sons Ltd as on 05 March 2026?

    The current stock price of BL Kashyap & Sons Ltd as on 05 March 2026 is ₹50.6.

    What is the High / Low of BL Kashyap & Sons Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of BL Kashyap & Sons Ltd stocks is ₹80.1/42.7.

    What is the Stock P/E of BL Kashyap & Sons Ltd?

    The Stock P/E of BL Kashyap & Sons Ltd is 128.

    What is the Book Value of BL Kashyap & Sons Ltd?

    The Book Value of BL Kashyap & Sons Ltd is 23.3.

    What is the Dividend Yield of BL Kashyap & Sons Ltd?

    The Dividend Yield of BL Kashyap & Sons Ltd is 0.00 %.

    What is the ROCE of BL Kashyap & Sons Ltd?

    The ROCE of BL Kashyap & Sons Ltd is 8.08 %.

    What is the ROE of BL Kashyap & Sons Ltd?

    The ROE of BL Kashyap & Sons Ltd is 2.00 %.

    What is the Face Value of BL Kashyap & Sons Ltd?

    The Face Value of BL Kashyap & Sons Ltd is 1.00.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in BL Kashyap & Sons Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
    Explore Industry-wise Stock Analysis Reports